Description: Quoth Wikipedia ever moreLinagliptin INN previously known as BI1356 marketed under trade names Tradjenta US and Trajenta worldwide is a dipeptidyl peptidase4 inhibitor developed by Boehringer Ingelheim for treatment of diabetes mellitus type 2Oncedaily linagliptin was approved by the US Food and Drug Administration FDA on 2 May 2011 for treatment of type 2 diabetes It is being marketed by Boehringer Ingelheim and LillyLinagliptin may cause severe joint pain
By: AdamStanislav
Date: 2017-04-26
Block Explorer: View Transaction
Downloads: 111
Filesize: 4791
Download
Linagliptin sourced from Openclipart is licensed under CC0 1.0
* Note: Date might not match original source and might be an educated guess.